Ramosetron — CAS 132907-72-3

Ramosetron is a selective 5-HT3 receptor antagonist used for the prevention of chemotherapy-induced nausea and vomiting (CINV) and the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D). Mediocon Inc manufactures GMP-compliant Ramosetron at its Aurangabad facility.

• Prevention of chemotherapy-induced nausea and vomiting (CINV)
• Treatment of irritable bowel syndrome (IBS-D)
• 5-HT3 serotonin receptor antagonist
• Postoperative nausea and vomiting (PONV)

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support